INmune Bio, Inc.
INMB
$1.97
-$0.01-0.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.42% | -25.63% | -41.64% | -19.76% | -35.04% |
| Total Receivables | -36.86% | -47.36% | -42.30% | -37.25% | 66.81% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -50.15% | -81.71% | -79.96% | -42.74% | -62.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.52% | -29.72% | -43.26% | -21.40% | -32.53% |
|
|
|||||
| Total Current Assets | 1.52% | -29.72% | -43.26% | -21.40% | -32.53% |
| Net Property, Plant & Equipment | 197.52% | -28.53% | -25.85% | -24.55% | -22.44% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 603.70% | -53.77% | -39.69% | -36.43% | -37.69% |
| Total Assets | -28.16% | -19.29% | -30.59% | -15.82% | -24.77% |
|
|
|||||
| Total Accounts Payable | -17.36% | -22.55% | -17.24% | 188.16% | 289.18% |
| Total Accrued Expenses | 32.37% | -- | -28.57% | -30.38% | 1,444.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -95.69% | -98.07% | -98.61% | -73.99% | -49.42% |
| Total Finance Division Other Current Liabilities | -1.92% | 12.12% | 5.73% | 10.69% | -6.96% |
| Total Other Current Liabilities | -1.92% | 12.12% | 5.73% | 10.69% | -6.96% |
| Total Current Liabilities | -42.95% | -54.57% | -60.89% | -3.71% | 15.29% |
|
|
|||||
| Total Current Liabilities | -42.95% | -54.57% | -60.89% | -3.71% | 15.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -28.26% | -44.17% | -38.54% | -33.95% | -30.45% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -42.65% | -54.36% | -60.42% | -21.48% | -19.37% |
|
|
|||||
| Common Stock & APIC | 26.93% | 26.21% | 23.01% | 23.09% | 15.04% |
| Retained Earnings | -39.15% | -30.90% | -34.77% | -36.65% | -36.27% |
| Treasury Stock & Other | -7.01% | 8.82% | 28.04% | -40.95% | -0.14% |
| Total Common Equity | -20.43% | 5.13% | -14.04% | -11.97% | -28.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -20.43% | 5.13% | -14.04% | -11.97% | -28.37% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -22.15% | 2.24% | -15.84% | -13.54% | -26.80% |
|
|
|||||